Author:
Wenham Robert M.,Lapolla James,Lin Hui-Yi,Apte Sachin M.,Lancaster Johnathan M.,Judson Patricia L.,Gonzalez-Bosquet Jesus,Herschberger Amber,Havrilesky Laura J.,Secord Angeles Alvarez
Subject
Obstetrics and Gynecology,Oncology
Reference50 articles.
1. Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer;Monk;Gynecol Oncol,2005
2. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N Engl J Med,2011
3. A phase 3 trial of bevacizumab in ovarian cancer;Perren;N Engl J Med,2011
4. OCEANS: a randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC);Aghajanian;J Clin Oncol,2011
5. Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study;Burger;J Clin Oncol,2007
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献